Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE BioElectronics Corporation
FREDERICK, Md., March 19, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has begun distribution in Italy of its RecoveryRx™ product line with Biomax Spa (www.biomax.it). RecoveryRx™ (www.recoveryrx.co) medical devices provide labor free, 24-hour therapy to reduce pain, inflammation, and to accelerate healing.
Biomax Spa is the Italian market leader in the oral implant and bone regeneration sectors and has been distributing Biomet/3i product line for 20 years. Biomax Spa also markets and distributes the Zest Anchors over dentures line and the Mectron PiezoSurgery System.
"The Biomax Team is very excited to add BioElectronics' RecoveryRx™ products to its selective roster of products. We have recently joined forces with One Globe Biotechnology and with Medical Distribution Srl to expand our 50+ sales representatives to serve all Italian pharmacy and hospital supply chains," said Tino Valdesolo, President of Biomax.
"We are pleased to add Biomax's experienced and successful distributors to our expanding hospital, clinic, and medical offices network," said Ben Fichter, BIEL Marketing Manager. Italy, with a population of more than 60 million, is a potential major market for BIEL.
About BioElectronics Corporation
BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical procedures and wound care. For more information, please visit www.bielcorp.com.
©2012 PR Newswire. All Rights Reserved.